Report post
The rise of biotech companies is fueling Optimism in the industry. Forbes highlights key factors for success in building a $4.8 billion biotech giant. China's potential to lead the bio-revolution is explored. Jefferies' top analyst predicts a biotech boom in 2024, buoyed by deals like Bristol Myers-Karuna. The sector is poised for growth as ideas and investments flourish.

The World's Leading Crypto Trading Platform

Get my welcome gifts